Infliximab versus ciclosporin in steroid resistant acute severe ulcerative colitis: a model-based cost-utility analysis of data from CONSTRUCT pragmatic trial

• Auteurs principaux: Mohammed Fasihul Alam (Auteur), Mirella Longo (Auteur), David Cohen (Auteur), Sam Groves (Auteur), Laith Alrubaiy (Auteur), Hayley A. Hutchings (Auteur), Alan Watkins (Auteur), Shaji Sebastain (Auteur), John G. Williams (Auteur)
• Format: Livre
• Publié: BMC, 2023-03-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Abstract Background There is limited evidence in the literature on the long-term effectiveness and cost-effectiveness of treatments for Acute Severe Ulcerative Colitis (ASUC). The study aimed to perform decision analytic model-based long-term cost-utility analysis (CUA) of infliximab versus ciclospo...